Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rare disease

Fibrodysplasia ossificans progressiva

  • 5 clinical trials
  • 2 recruiting
  • 10 countries
Quick filters

5 Clinical trials

Fibrodysplasia ossificans progressiva

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Amsterdam UMC

Fibrodysplasia ossificans progressiva

Recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Incb000928
  • Sponsor:Incyte Corp.

Fibrodysplasia ossificans progressiva

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:SARACATINIB
  • Sponsor:Amsterdam UMC

Fibrodysplasia ossificans progressiva

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:(R)‑Tetrahydrofuran‑3‑Yl 4‑(6‑(5‑(4‑Ethoxy‑1‑Isopropylpiperidin‑4‑Yl)Pyridin-2-Yl)Pyrrolo[1,2-B]Pyridazin-4-Yl)Piperazine-1-Carboxylate Sesquisuccinate
  • Sponsor:Clementia Pharmaceuticals Inc. An Ipsen Company

Fibrodysplasia ossificans progressiva

Not recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Garetosmab
  • Sponsor:Regeneron Pharmaceuticals Inc.
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.